多做大腸鏡，降低大腸癌死亡率嗎?


又是一個從加拿大健保資料庫出來的paper
自1993追到2006年底，colonoscope的執行增加了四倍
每增加1%, 減少大腸癌死亡 3%

這是一個統計數字的把戲嗎?
editorial認為文章沒有把其它降低大腸癌發生率的因子統計進去
美國的study也證明大腸癌的死亡率一直降，even before colonoscope



Colonoscopy Use Associated with Reduction in Colorectal Cancer Mortality

Long-term follow-up data showed a 3% decrease in the risk for death from CRC for every 1% increase in the colonoscopy rate.

Evidence that colonoscopy use reduces the incidence of colorectal cancer (CRC), presumably through polypectomy, comes primarily from fecal occult blood testing trials. No randomized controlled trials testing whether colonoscopy use prevents CRC have been performed.

In one of several ongoing studies on colonoscopy from Ontario, Canada, investigators analyzed colonoscopy rates and CRC incidence and mortality through December 2006 for all people aged 50 to 90 who had been residents of Ontario on January 1, 1993. During the 14 years of follow-up, the overall colonoscopy rate increased roughly fourfold, with increases evident in all regions of the province. For every 1% increase in the overall colonoscopy rate, the hazard ratio for death from CRC decreased by 3%.

Comment: This study adds to several lines of indirect evidence that colonoscopy use is associated with reductions in CRC mortality. Whether it leads to reductions specifically in the incidence of proximal colon cancer remains unclear. As noted in an accompanying editorial, the study design does not allow other potential contributors to the reduction in cancer incidence to be excluded. These include reduction in risk factors or improvements in treatment, which might also have shown regional variation.

— Douglas K. Rex, MD

Published in Journal Watch Gastroenterology August 13, 2010
Citation(s):

Rabeneck L et al. Association between colonoscopy rates and colorectal cancer mortality. Am J Gastroenterol 2010 Jul; 105:1627.

* Medline abstract (Free)

Sandler RS. Colonoscopy and colorectal cancer mortality: Strong beliefs or strong facts? Am J Gastroenterol 2010 Jul; 105:1633.

* Medline abstract (Free)

https://docs.google.com/fileview?id=0B278nGJMQBk7Nzk4NTdhYTQtMzAyMi00ZTFlLTliNzMtYTI5MTQyNzQ1ODVh&hl=zh_TW

https://docs.google.com/fileview?id=0B278nGJMQBk7OGYxZWUwZTMtNmVkZS00MWJmLTk1MDYtOTdkNjFkZWVjZWNj&hl=zh_TW

留言

張貼留言

這個網誌中的熱門文章

即便是用IGRA, 有時也要等大於三個月才能決定TB contact

圖片
接觸TB後，TST大抵上2-12週轉陽，IGRA大抵上6-10週，但IGRA可以長到3個月以上 TB Tests Can Have a Lengthy Window Period Two studies suggest that interferon- release assay conversion sometimes occurs more than 3 months after exposure to active tuberculosis. Increasingly, interferon- release assays (IGRAs) are being used for diagnosing latent tuberculosis (TB). Although the tuberculin skin test (TST) traditionally used for this purpose converts to positive within 2 to 12 weeks after an individual is exposed to someone with active TB, the interval for IGRA conversion has remained unclear. Current guidelines recommend repeating an initially negative IGRA after 6 to 10 weeks, but this recommendation is not based on controlled studies. Two recent investigations address this issue. Anibarro and colleagues conducted a longitudinal prospective analysis among contacts of TB patients in Spain. The 152 contacts received a TST and an IGRA at first visit; for individuals with negative or conflicting results, t
閱讀完整內容

TG無用論，不用吃fenofibrate了，除非> 500mg/dl

圖片
不用管TG levels，除非高到>500 好好吃東西，好好運動，比吃藥重要!! Don't Miss the New AHA Recommendations on Triglycerides A new scientific statement raises the threshold for pharmacologic treatment of hypertriglyceridemia. The following was published as a "Voices" blog on CardioExchange , an online forum for cardiology news and discussion. The blog prompted a lively conversation, which you can access and join by registering for CardioExchange. I've been surprised at the lack of fanfare surrounding the American Heart Association's recently published scientific statement on triglycerides and cardiovascular disease (CVD). The attention it did receive focused on the lower fasting triglyceride level that is now considered optimal: <100 mg/dL. In my opinion, the real headline was the committee's important statements in support of less drug treatment — in particular, the recommendation for a substantial increase in the triglyceride level that should trigger consideratio
閱讀完整內容